Oculis News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

13.11.24	Oculis to Present at the Stifel 2024 Healthcare Conference (GlobeNewswire)
07.11.24	Oculis Reports Q3 2024 Financial Results and Provides Company Updates (GlobeNewswire)
21.10.24	Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees (GlobeNewswire)
09.10.24	Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis (RTTNews)
02.10.24	Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer (GlobeNewswire)
27.08.24	Oculis Publishes Consolidated Q2 Financial Statements and MD&A (GlobeNewswire)
27.08.24	Oculis Reports Q2 Financial Results and Provides Recent Company Update (GlobeNewswire)
15.08.24	Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer (GlobeNewswire)
10.06.24	Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy (GlobeNewswire)
04.06.24	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities (GlobeNewswire)
30.05.24	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
17.05.24	Oculis updates share capital for its existing at-the-market offering program (GlobeNewswire)
08.05.24	Oculis Reports Q1 2024 Financial Results and Provides Company Updates (GlobeNewswire)
07.05.24	Oculis Publishes Invitation to the Annual General Meeting (GlobeNewswire)
22.04.24	Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market (GlobeNewswire)
17.11.23	Expert Ratings for Oculis Holding (Benzinga)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	310.30	2.07 %	K V
Part Grp Hldg	1’248.50	1.67 %	K V
Novartis	92.79	1.34 %	K V
Geberit	523.20	1.28 %	K V
Roche Hldg G	253.60	1.00 %	K V
UBS Group	28.13	-0.04 %	K V
CieFinRichemont	117.60	-0.04 %	K V
Swiss Life Hldg	726.20	-0.14 %	K V
Kuehne+Nagel Int	207.40	-0.29 %	K V
Zurich Insur Gr	546.00	-0.29 %	K V